-
Six years ago, The New England Journal of Medicine reported1,2 Moseley's study of the use of arthroscopy to treat knee osteoarthritis (OA).
-
-
Everyone agrees that these are difficult times for physicians who wish to start working in clinical trials. They often have trouble enrolling in new trials, and the budgeting and documentation realities may lead to disillusionment before their first studies are completed.
-
When the founders of HOPE Research Institute of Phoenix, AZ, began to envision their new clinical research (CR) organization, they relied upon both their past successes and challenges in drawing plans.
-
The clinical research industry is bracing itself for the next phase of the federal government's ClinicalTrials.gov research database and the addition of CT results.
-
There are a number of ways clinical trial (CT) sites and investigators could improve the informed consent process, and CT experts offer a variety of suggestions for how to make this happen.
-
For clinical trial enrollment success sites need to have solid, long-term relationships with clinicians who refer patients to studies.
-
If you believe the informed consent process truly is a process and not just a multi-page document to get someone to sign, then it's important to develop strategies for improving both the process and the IC form.
-
Four new Centers of Excellence for Research on Complementary and Alternative Medicine (CERCs) have been added by the National Institutes of Health's National Center for Complementary and Alternative Medicine (NCCAM).
-
The U.S. Department of Health and Human Services announced in October that it will send Food and Drug Administration (FDA) staff to China, India, Europe, and Latin America before the end of 2008.
